Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tonifying Qi and Activating Blood Chinese herbal prescriptions for myocardial infarction
ChiCTR2100047435Phase 4Recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Dec 2020
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of naoxintong, buyang huanwu decoction and yangyintongnao in myocardial infarction (MI) (4 arms), sponsored by Beijing Hospital of Traditional Chinese Medicine. Primary endpoints: Incidence of heart failure, Curative effect of Chinese medicine syndrome and 29 more. Started Dec 2020; status: recruiting.
02
Drugs
naoxintongbuyang huanwu decoctionyangyintongnao
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR2100047435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100047435.